Over-the-counter treatments are widely available, but ophthalmologists warn the potential side effects can be harmful.
It contains the prostaglandin analog bimatoprost. Other over-the-counter-products — GrandeLash, RevitaLash — are not FDA-approved (that’s not to say they’re unlicensed, just that they’ve ...
The DURYSTA market potential seems strong due to the increasing prevalence of glaucoma, the need for long-term, non-adherence-dependent treatments, and its advantage over daily eye drops. With an ...
Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果